NOVARTIS N (Germany) Analysis
| NOT Stock | EUR 143.42 1.56 1.10% |
200 Day MA 111.5552 | 50 Day MA 126.7872 |
Long Term Debt is likely to drop to about 24.3 B in 2026. Short and Long Term Debt is likely to drop to about 5.5 B in 2026 NOVARTIS N's financial risk is the risk to NOVARTIS N stockholders that is caused by an increase in debt.
Given that NOVARTIS N's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which NOVARTIS N is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of NOVARTIS N to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, NOVARTIS N is said to be less leveraged. If creditors hold a majority of NOVARTIS N's assets, the Company is said to be highly leveraged.
Total Stockholder Equity is likely to gain to about 48.3 B in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.7 B in 2026. . NOVARTIS N is overvalued with Real Value of 131.95 and Hype Value of 143.9. The main objective of NOVARTIS N stock analysis is to determine its intrinsic value, which is an estimate of what NOVARTIS N is worth, separate from its market price. There are two main types of NOVARTIS N's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect NOVARTIS N's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of NOVARTIS N's stock to identify patterns and trends that may indicate its future price movements.
The NOVARTIS N stock is traded in Germany on Munich Exchange, with the market opening at 08:00:00 and closing at 20:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. NOVARTIS N is usually not traded on GermanUnityDay, Christmas Eve ( 2025 ), Christmas Day, Boxing Day, New Year 's Eve ( 2025 ), New Year 's Day, Good Friday, Easter Monday, International Workers ' Day. NOVARTIS Stock trading window is adjusted to Europe/Berlin timezone.
NOVARTIS |
NOVARTIS Stock Analysis Notes
The company has Price/Earnings To Growth (PEG) ratio of 2.85. NOVARTIS N last dividend was issued on the 4th of March 1970. The entity had 6:5 split on the 4th of October 2023.NOVARTIS N Quarterly Total Revenue |
|
NOVARTIS N Investment Alerts
| NOVARTIS is showing solid risk-adjusted performance over 90 days |
NOVARTIS Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 160.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NOVARTIS N's market, we take the total number of its shares issued and multiply it by NOVARTIS N's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Management Efficiency
At this time, NOVARTIS N's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 1 B in 2026, whereas Non Current Liabilities Total is likely to drop slightly above 26.8 B in 2026. NOVARTIS N's management efficiency ratios could be used to measure how well NOVARTIS N manages its routine affairs as well as how well it operates its assets and liabilities.Leadership effectiveness at NOVARTIS N is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield 0.0488 | Forward Dividend Yield 0.0488 |
Technical Drivers
As of the 1st of March, NOVARTIS N secures the Market Risk Adjusted Performance of 1.87, mean deviation of 0.794, and Risk Adjusted Performance of 0.3294. Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of NOVARTIS N, as well as the relationship between them.NOVARTIS N Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to NOVARTIS N changes than the simple moving average.
NOVARTIS N Predictive Daily Indicators
NOVARTIS N intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NOVARTIS N stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NOVARTIS N Forecast Models
NOVARTIS N's time-series forecasting models are one of many NOVARTIS N's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NOVARTIS N's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.NOVARTIS N Total Assets Over Time
NOVARTIS N Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the NOVARTIS N's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of NOVARTIS N, which in turn will lower the firm's financial flexibility.NOVARTIS Long Term Debt
Long Term Debt |
|
About NOVARTIS Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NOVARTIS N prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NOVARTIS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NOVARTIS N. By using and applying NOVARTIS Stock analysis, traders can create a robust methodology for identifying NOVARTIS entry and exit points for their positions.
NOVARTIS N is entity of Germany. It is traded as Stock on MU exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NOVARTIS N to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Additional Tools for NOVARTIS Stock Analysis
When running NOVARTIS N's price analysis, check to measure NOVARTIS N's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOVARTIS N is operating at the current time. Most of NOVARTIS N's value examination focuses on studying past and present price action to predict the probability of NOVARTIS N's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOVARTIS N's price. Additionally, you may evaluate how the addition of NOVARTIS N to your portfolios can decrease your overall portfolio volatility.